Sermorelin: What the Research Shows

Research Use Only: This article summarises published scientific literature for laboratory and research audiences. It is not medical advice, and Sermorelin is not approved for human or veterinary use in this context.

What is Sermorelin?

Sermorelin is a synthetic peptide corresponding to the first 29 amino acids of growth-hormone-releasing hormone (GHRH 1-29), the active fragment of GHRH. It is studied in the research literature as a GHRH-receptor agonist and is one of the classic reference peptides in growth-hormone-axis research.

Where Sermorelin sits in the research literature

The evidence base includes preclinical and clinical research on GHRH-receptor signalling and the growth-hormone axis. Any findings should be interpreted within their study context.

Reported areas of preclinical interest

• GHRH receptor agonism: studied as the active GHRH fragment acting on the growth-hormone axis.
• Growth-hormone signalling: examined as a reference compound in axis research.

Why the “research use only” label matters

The Sermorelin supplied here is a research material and is intended strictly for laboratory and scientific research, not for human or veterinary consumption.

Handling and storage

Store lyophilised peptide cool, dry and away from light, and refrigerate reconstituted solution, using it within the indicated stability window. Follow the documentation supplied with each batch.

Frequently asked questions

What does Sermorelin do in research?

It is studied as a GHRH (1-29) analogue and GHRH-receptor agonist acting on the growth-hormone axis in laboratory models.

Is Sermorelin approved for human use?

The material supplied here is a research chemical only and is not intended for human or veterinary use.

Key takeaways

Sermorelin is a GHRH (1-29) analogue and a classic reference peptide in growth-hormone-axis research. It is a research material only. Review the Sermorelin research product.

References

References sourced via PubMed.

1. Aitman TJ, Rafferty B, Coy D, Lynch SS, Clayton RN. Bioactivity of growth hormone releasing hormone (1-29) analogues after SC injection in man. Peptides. 1989;10(1):1-4. DOI · PubMed 2546126.

Disclaimer: This article is for informational and educational purposes for a research audience. It is not medical advice. Products referenced are sold strictly for laboratory research and are not for human or veterinary use.